The FDA approved Addyi (flibanserin), a libido-enhancing drug, in postmenopausal women under the age of 65. Experts explain ...
Morning Overview on MSN
A tiny gut-made molecule could rewrite diabetes care
A small molecule made by gut microbes is rapidly emerging as one of the most intriguing new levers for controlling blood ...
Medtronic initially secured FDA clearance for the MiniMed 780G pump for people with Type 1 diabetes in early 2023. This past ...
Eli Lilly and Company (NYSE: LLY) today announced positive topline results from the ATTAIN-MAINTAIN trial. The Phase 3 study ...
The children's author said she was advised by her hospital diabetes team to be on the closed loop system for three months ...
RANCHO CUCAMONGA, CA / ACCESS Newswire / December 15, 2025 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the U.S. Food and Drug Administration ("FDA") has approved the Company's Abbre ...
RANCHO CUCAMONGA, CA / / December 15, 2025 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the U.S. Food and ...
Ozempic has hit the Indian market and will be available at Rs 2,200 per week. But did you know that there are alternatives ...
For almost two-thirds of his life, Nick Jonas has lived with a chronic condition — type 1 diabetes. The Jonas Brothers-famed ...
Some people need insulin only temporarily — for example, during infections, after surgery, or when glucose levels are ...
In 2026, Novo Nordisk’s patent on semaglutide will expire in several countries, including India and China. Industry experts ...
Women with polycystic ovary syndrome are increasingly turning to blockbuster weight-loss drugs from Eli Lilly and Novo ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback